Icotinib With Concurrent Radiotherapy Versus Etoposide/Cisplatin With Concurrent Radiotherapy in Stage III Non-small Cell Lung Cancer With EGFR 19/21 Mutation
Latest Information Update: 02 Nov 2022
At a glance
- Drugs Icotinib (Primary) ; Cisplatin; Etoposide
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Betta Pharmaceuticals Co Ltd
Most Recent Events
- 20 Aug 2014 New trial record